Twist Bioscience (TWST) Total Liabilities (2017 - 2026)

Twist Bioscience has disclosed Total Liabilities across 10 years of filings, most recently posting $221.1 million for Q1 2026.

• In Q1 2026, Total Liabilities rose 42.19% year-over-year to $221.1 million; the TTM figure through Mar 2026 stood at $221.1 million (up 42.19% YoY), while the FY2025 annual figure was $168.9 million, up 19.25% from the prior year.
• Total Liabilities improved to $221.1 million in Q1 2026, from $182.0 million in the prior quarter.
• Over the last five years, Total Liabilities for TWST reached as high as $221.1 million in Q1 2026 and fell as low as $141.6 million in Q3 2024.
• The 5-year median for Total Liabilities is $155.5 million (2025), against an average of $160.5 million.
• Annual changes were most pronounced in 2022 — Total Liabilities surged 2627.42% — and 2023, when it fell 12.75%.
• A 5-year view of Total Liabilities shows it stood at $163.6 million in 2022, then slipped by 12.75% to $142.8 million in 2023, then grew by 6.91% to $152.6 million in 2024, then advanced by 19.23% to $182.0 million in 2025, then climbed by 21.5% to $221.1 million in 2026.
• According to Business Quant data, Total Liabilities over the past three periods registered $221.1 million, $182.0 million, and $168.9 million for Q1 2026, Q4 2025, and Q3 2025 respectively.